PTAB statistics

PTAB Trial Statistics as of June 30, 2015

As of June 30, 2015, USPTO records show 3,540 AIA trial petitions filed since September 16, 2012 (3,160 IPR, 362 CBM, 10 PGR, 8 derivation). The Board had instituted trial on 1,606 petitions and denied 953 (62.8% instituted) and had issued 497 final written decisions. In fiscal year 2015 to that date, 1,459 petitions were filed.

Key Facts

As of
June 30, 2015
Fiscal year
FY2015
Petitions filed (cumulative)
3,540
Institution rate (cumulative)
62.8%
Petitions filed (FY2015 to date)
1,459
Data retrieved
October 31, 2026
On this page
  1. Cumulative Figures as of June 30, 2015
  2. Fiscal Year 2015 to Date
  3. Change Since June 4, 2015
  4. Trial Types Covered
  5. How These Figures Were Compiled
  6. Related Statistics

This page gives Patent Trial and Appeal Board trial figures as of June 30, 2015, which falls in fiscal year 2015 (October 1, 2014 to September 30, 2015). The cumulative figures run from September 16, 2012, when AIA trials began. The full year is covered on the FY2015 statistics page.

Cumulative Figures as of June 30, 2015

Events from September 16, 2012 to June 30, 2015, by trial type:

MeasureIPRPGRCBMDERTotal
Petitions filed3,1601036283,540
Institution decisions: instituted1,422218201,606
Institution decisions: denied8542943953
Institution rate (by petition)62.5%50.0%65.9%0.0%62.8%
Final written decisions4420550497
Terminations without a final written decisionCount
Settlements360
Adverse judgment0
Dismissed0
Other terminations27

Fiscal Year 2015 to Date

Events from October 1, 2014 to June 30, 2015:

MeasureIPRPGRCBMDERTotal
Petitions filed1,319812931,459
Institution decisions: instituted6832750760
Institution decisions: denied5012380541
Institution rate (by petition)57.7%50.0%66.4%—58.4%
Final written decisions2920380330
Terminations without a final written decisionCount
Settlements216
Adverse judgment0
Dismissed0
Other terminations19

Change Since June 4, 2015

Between the previous dated page (June 4, 2015) and June 30, 2015, 162 petitions were filed, 65 trials were instituted, 68 petitions were denied institution and 42 final written decisions issued. The cumulative institution rate moved from 63.5% to 62.8%.

Trial Types Covered

3,160 of the 3,540 petitions (89.3%) were for inter partes review, which challenges patent claims on prior-art grounds under 35 U.S.C. chapter 31. The remainder were for covered business method review (362), post-grant review under chapter 32 (10) and derivation proceedings (8). Institution standards differ by proceeding; see the threshold standards.

How These Figures Were Compiled

The figures are counted from USPTO Open Data Portal records retrieved on October 31, 2026, keeping only events dated on or before June 30, 2015: a petition by its filing date, an institution decision by its decision date, and a final written decision or termination by its date. They are a reconstruction from the current records, not the USPTO’s report of that date, and may differ from statistics the USPTO published at the time. Final written decision outcomes are not reported because the records state them for too few decisions. The methodology gives the counting rules in full.

Frequently Asked Questions

How many AIA trial petitions had been filed as of June 30, 2015?

USPTO records show 3,540 petitions filed from September 16, 2012 to June 30, 2015: 3,160 IPR, 362 CBM, 10 PGR and 8 derivation.

What was the PTAB institution rate as of June 30, 2015?

Cumulatively, 62.8% by petition: 1,606 instituted and 953 denied. In FY2015 to that date the rate was 58.4%.

Primary Sources

  1. USPTO Open Data Portal (PTAB trial proceedings and decisions data)
  2. USPTO Patent Trial and Appeal Board statistics
  3. 35 U.S.C. chapter 31 (inter partes review)
  4. 35 U.S.C. chapter 32 (post-grant review)
  5. 37 C.F.R. Part 42 (trial practice before the PTAB)

Educational information; not legal advice. Statutes, rules and USPTO practice change. Confirm against the primary sources and consult a registered patent practitioner before acting. Disclaimer.